Self-Powered Micro-Line Patch Revolutionizes biomarker Monitoring

Researchers have developed a self-powered micro-line patch capable of monitoring a range of health biomarkers without the need for blood draws or reliance on batteries or external devices. In initial proof-of-concept testing using synthetic skin,the patches demonstrated the ability to collect biomarker samples over periods ranging from 15 minutes to 24 hours.

“Biomarkers are measurable indicators of biological processes, which help us monitor health and diagnose medical conditions,” explains Michael Daniele, the corresponding author of the research. “The majority of conventional biomarker tests rely on blood samples. Beyond being unpleasant for many, blood samples also present challenges for healthcare professionals and technology developers. blood is a complex system, requiring the removal of platelets, red blood cells, and other components before the relevant fluid can be tested.”

“Our patch utilizes micro-actuators to sample the fluid surrounding cells in the dermal and epidermal layers just below the skin’s surface,” Daniele explains, professor of electrical engineering at NC State and in the joint biomedical engineering department at NC State and the University of North Carolina. “This fluid is called dermal interstitial fluid (ISF),and it contains nearly all the same biomarkers found in blood. Importantly, ISF provides a cleaner sample – it doesn’t require the same level of pre-processing as blood before testing. This substantially simplifies the biomarker testing process.”

More specifically,Daniele and his team created a fully passive micro-actuator patch that does not

Key Takeaways:

• Non-Invasive Monitoring: The patch eliminates the need for blood draws,offering a more cozy biomarker monitoring experiance.
• simplified Sample Preparation: ISF samples require less pre-processing compared to blood,streamlining the testing process.
• Self-Powered Operation: The patch operates without batteries or external power sources, enhancing portability and convenience.
• extended Monitoring: The patch can collect samples over extended periods, from 15 minutes to 24 hours, enabling continuous health tracking.

FAQ:

What is dermal interstitial fluid (ISF)?

ISF is the fluid surrounding cells in the dermal and epidermal layers of the skin. It contains biomarkers similar to those found in blood but requires less processing for analysis.

How does the patch work?

The patch uses micro-actuators to gently collect ISF samples from the skin.

What types of biomarkers can be monitored?

The patch is designed to monitor a range of biomarkers, offering potential applications in various health monitoring scenarios.

Is this technology currently available to consumers?

This technology is currently in the proof-of-concept stage.Further research and development are needed before it becomes commercially available.

This innovative micro-line patch represents a meaningful step forward in non-invasive health monitoring. by simplifying biomarker testing and eliminating the need for blood draws, this technology has the potential to transform preventative healthcare and disease management. Future research will focus on refining the patch design, expanding the range of detectable biomarkers, and conducting clinical trials to validate its effectiveness in real-world settings. We anticipate this technology will pave the way for personalized, continuous health monitoring, empowering individuals to take proactive control of their well-being.

Publication date: 2025/08/18 19:58:15